menu search

MCK / McKesson Corporation: Still Trading Below Intrinsic Value

McKesson Corporation: Still Trading Below Intrinsic Value
McKesson reported solid second quarter results. Not only is the business recession-resilient, it also settled the opioid litigations in 2022. Read More
Posted: Dec 13 2022, 13:12
Author Name: Seeking Alpha
Views: 111866

MCK News  

McKesson (MCK) Beats on Q2 Earnings, Raises '23 EPS View

By Zacks Investment Research
November 2, 2023

McKesson (MCK) Beats on Q2 Earnings, Raises '23 EPS View

McKesson's (MCK) second-quarter fiscal 2024 results benefit from growth in the United States. Divestment hurts the International segment. more_horizontal

Here's What Key Metrics Tell Us About McKesson (MCK) Q2 Earnings

By Zacks Investment Research
November 1, 2023

Here's What Key Metrics Tell Us About McKesson (MCK) Q2 Earnings

While the top- and bottom-line numbers for McKesson (MCK) give a sense of how the business performed in the quarter ended September 2023, it could be more_horizontal

McKesson Corporation (MCK) Q2 2024 Earnings Call Transcript

By Seeking Alpha
November 1, 2023

McKesson Corporation (MCK) Q2 2024 Earnings Call Transcript

McKesson Corporation (NYSE:MCK ) Q2 2024 Earnings Conference Call November 1, 2023 4:30 PM ET Company Participants Rachel Rodriguez - Vice President o more_horizontal

McKesson lifts annual profit forecast after strong quarterly results

By Reuters
November 1, 2023

McKesson lifts annual profit forecast after strong quarterly results

Drug distributor McKesson Corp on Wednesday raised its annual profit forecast, banking on strong demand for specialty medicines. more_horizontal

This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar

By Zacks Investment Research
October 30, 2023

This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank. more_horizontal

Are Investors Undervaluing McKesson (MCK) Right Now?

By Zacks Investment Research
October 25, 2023

Are Investors Undervaluing McKesson (MCK) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Neverthe more_horizontal

Bankrupt Rite Aid resolves drug supply dispute with McKesson

By Reuters
October 17, 2023

Bankrupt Rite Aid resolves drug supply dispute with McKesson

Pharmacy chain Rite Aid has settled a critical dispute with drug supplier McKesson Corp to ensure that customers' prescriptions will continue to be fi more_horizontal

McKesson (MCK) Upgraded to Strong Buy: Here's What You Should Know

By Zacks Investment Research
October 12, 2023

McKesson (MCK) Upgraded to Strong Buy: Here's What You Should Know

McKesson (MCK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy). more_horizontal


Search within

Pages Search Results: